The following is a summary of “Exploring Perceived Barriers and Facilitators for Implementing Acute Pain Clinical Trials: A Mixed-Methods Analysis of Ketamine Infusions for Sickle Cell Pain,” published in the March 2025 issue of Journal of Pain Research by Kenney et al. Ketamine’s opioid-sparing potential offers a possible alternative to high-dose opioids for treating vaso-occlusive […]
The post Barriers and Facilitators to Inpatient Ketamine Trials for SCD Pain first appeared on Physician’s Weekly.
